Rostock Group has established Genomics Center in Moscow
(Moscow, Sept. 29, 2010) – Rostock Groups has announced today that it opened own research center in genomics. Genomics Center will closely collaborate with N.I.Vavilov Institute of General Genetics of Russian Academy of Sciences. The Center is established for wide-scale genetics research in the area of neurodegenerative human diseases. Genomics Center is equipped with the newest research tools, including the only-in-Russia DNA sequencer HiSeq 2000, the most powerful analytical instrument for deep DNA decoding.
According to the founder and President of Rostock Group Mr. Alexander Chikunov, “own research center will allow the Group to do research to its own initiative. It will also support the development of genetic programs in Russia as well as Russian research personnel training”.
GenomicsCenteris Russian arm of Rostock Biotech Research, a fundamental-science subsidiary of Rostock Group.
The immediate objective of the Center is search for new diagnostics and treatments for Alzheimer’s disease, schizophrenia and other ailments with a significant genetic component in pathogenesis. In particular, the research team will reveal respective gene mutations and develop target-specific pharmaceuticals for the diseases.
The Center’s research will be led by Dr. Eugene Rogaev, Russian State Prize Winner, one of the developers of methods for individual genomic identifications and discoverers of genes of family variants of Alzheimer’s disease. Recently, Dr. Rogaev and his team have revealed the gene of Royal Disease, a specific form of hemophilia (Science 06 October 2009; 10.1126/science.1180660).
Topic: Genomics Center